Global X Japan Co. Ltd. Acquires 5,393 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Global X Japan Co. Ltd. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,682 shares of the medical equipment provider's stock after buying an additional 5,393 shares during the quarter. Intuitive Surgical makes up about 2.9% of Global X Japan Co. Ltd.'s investment portfolio, making the stock its 13th largest holding. Global X Japan Co. Ltd.'s holdings in Intuitive Surgical were worth $25,597,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in the stock. Norges Bank acquired a new position in Intuitive Surgical in the fourth quarter worth $2,401,493,000. GAMMA Investing LLC grew its position in shares of Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after acquiring an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC grew its position in shares of Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Capital Research Global Investors grew its position in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $313,769,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Barclays cut their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Evercore ISI cut their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Citigroup reissued a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Royal Bank Of Canada cut their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $588.95.

Intuitive Surgical Stock Down 0.0%

Shares of ISRG traded down $0.13 during trading hours on Friday, reaching $509.36. The company's stock had a trading volume of 2,827,555 shares, compared to its average volume of 1,682,019. The firm has a market cap of $182.56 billion, a price-to-earnings ratio of 74.69, a P/E/G ratio of 5.40 and a beta of 1.67. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The company has a 50 day moving average of $527.71 and a two-hundred day moving average of $537.69.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the company earned $1.50 EPS. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president now owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last 90 days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.